Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Clinical & Experimental Metastasis|July 4, 2012
Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patientsNicola Mozzillo, Paolo AsciertoRecenti Progressi in Medicina|January 27, 2015
[Using Twitter in oncology. Research, continuing education, and advocacy]Luciano De Fiore, Paolo AsciertoJournal of Translational Medicine|March 13, 2024
Shifting the paradigm: engaging multicellular networks for cancer therapyJoyce Hu, Paolo Ascierto, Alessandra Cesano, et al.Journal of Translational Medicine|November 26, 2020
Agnostic evaluation of ipilimumab and nivolumab association: a metanalysisPaolo Marchetti, Andrea Botticelli, Antonio Paolo Ascierto, et al.European Journal of Cancer (Oxford, England : 1990)|August 30, 2020
The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitionsChristoffer Gebhardt, Paolo Ascierto, Victoria Atkinson, et al.Ecancermedicalscience|March 3, 2015
Report from the second MIB (Melanoma Independent Board) Conference, 27-28 October 2014Alessandro Testori, Carlo Riccardo Rossi, Paolo Ascierto, et al.The Lancet. Oncology|December 4, 2018
Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?Jean Jacques Grob, Claus Garbe, Paolo Ascierto, et al.Medical Oncology (Northwood, London, England)|January 19, 2013
Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumorsMonica Cantile, Laura Marra, Renato Franco, et al.Ecancermedicalscience|December 21, 2016
Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisationLinda Cairns, Sandrine Aspeslagh, Andrea Anichini, et al.Dermatology (Basel, Switzerland)|June 6, 2013
Diagnostic services for melanoma in ItalyIgnazio Stanganelli, Paolo Ascierto, Riccardo Bono, et al.Pageof 3